skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Trivalent Influenza Vaccine (Code C2643)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Trivalent Influenza Vaccine

Definition: A synthetic vaccine consisting of hemagglutinin (HA) antigens derived from three inactivated influenza viruses, two different influenza type A strains and one influenza type B strain. Trivalent influenza vaccine (TIV) is formulated annually, based on influenza strains projected to be prevalent in the upcoming flu season. Upon administration, the TIV provides active immunization against the three influenza virus strains, thereby protecting against influenza infection. A form of TIV containing higher concentrations of HA antigens may be used in older patients to elicit a more effective immune response.

Display Name: Trivalent Influenza Vaccine

Label: Trivalent Influenza Vaccine

NCI Thesaurus Code: C2643 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0770694  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Flu prevention
Flu prophylaxis
Flu shot
Flu vaccination
Influenza Vaccine
Influenza Virus Vaccine, Trivalent, Types A and B
Trivalent Influenza Vaccine

External Source Codes: 
NSC Code 719208 (see NCI DTP info)
PDQ Closed Trial Search ID 38385
PDQ Open Trial Search ID 38385 (check for NCI PDQ open clinical trial info)
UMLS CUI C0770694

Other Properties:
     Name Value (qualifiers indented underneath)
Accepted_Therapeutic_Use_For Influenza Prophylaxis
code C2643
Contributing_Source CTRP
Contributing_Source NICHD
Legacy_Concept_Name Trivalent_Influenza_Vaccine
NICHD_Hierarchy_Term Trivalent Influenza Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom